PLYMOUTH MEETING, Pa., Dec. 5, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing ...

Rebecca Osberg works to raise awareness of 22q Deletion Syndrome and create community. Born with congenital heart disease and many other problems, Rebecca Osberg struggled to succeed in school and ...

A recent study led by UC Davis Health researchers provides new insights into the molecular changes linked to the rare genetic condition 22q11.2 deletion syndrome, or 22q. It found unique biomarkers ...

A content creator who suffers from a genetic disorder known as 22q syndrome has been flooded with well-wishes after being hospitalized. Justin Gigliotti from Boston—who goes by the name "Justin G" on ...

Manufacturer of transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, Zynerba Pharmaceuticals, Inc. ZYNE, completed enrollment for the 14-week Phase 2 INSPIRE trial of ...

Researchers studying the common genetic disorder chromosome 22q.11 deletion syndrome have identified key proteins that act together to regulate early embryonic development. One protein is essential to ...

Down syndrome is an easily recognized, well-known genetic disorder. But there is another genetic disorder that even more babies are born with and it is rarely talked about. It is called 22q11.2 ...

DEVON, Pa., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals (ZYNE), Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan ...

ATLANTA — A young Georgia girl is navigating a tough genetic disorder with a new companion by her side. Charli Jane Spradlin is no stranger to medical care. She was life-flighted to Children's ...